RAC 3.31% $1.61 race oncology ltd

Ann: Zantrene highly effective in EMD AML Mouse Model, page-41

  1. 57 Posts.
    lightbulb Created with Sketch. 12
    Otsuka, a $24B (AUD) pharamuitical conglomerate owns decitabine. Could a parntership with them be on the cards?
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.